P1582: CLINICAL CHARACTERISTICS AND INFECTION-RELATED OUTCOMES IN PATIENTS WITH LYMPHOID MALIGNANCIES WITH OR WITHOUT SECONDARY IMMUNODEFICIENCIES: RESULTS FROM A RETROSPECTIVE MULTI-DATABASE STUDY

• M. S. Davids,
• J. Richter,
• C. Anderson-Smits,
• M. Kamieniak,
• K. Ren,
• M. Hull,
• J. Multani,
• D. Shah,
• C. Siffel

Affiliations

M. S. Davids

1 Dana-Farber Cancer Institute, Boston

J. Richter

2 Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York

C. Anderson-Smits

3 Takeda Development Center Americas, Inc., Lexington, United States of America

M. Kamieniak

4 Takeda Pharma Sp.z.o.o., Warsaw, Poland

K. Ren

3 Takeda Development Center Americas, Inc., Lexington, United States of America

M. Hull

5 IQVIA, Falls Church, United States of America

J. Multani

5 IQVIA, Falls Church, United States of America

D. Shah

3 Takeda Development Center Americas, Inc., Lexington, United States of America

C. Siffel

3 Takeda Development Center Americas, Inc., Lexington, United States of America